Onyx Bio is a biotech company that offers a virtual immune system for faster and safer development of precision medicines
Onyx Bio has raised $8.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2026.
Onyx Bio's investors include Haystack.
Onyx Bio is headquartered in Berkeley, United States.
Onyx Bio is a biotech company that offers a virtual immune system for faster and safer development of precision medicines
Onyx Bio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Onyx Bio — Funding & Investors." VCBacked, February 25, 2026, https://www.vcbacked.co/company/onyx-bio. Accessed August 13, 2026.
VCBacked. (2026). Onyx Bio — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/onyx-bio
{{cite web |title=Onyx Bio — Funding & Investors |url=https://www.vcbacked.co/company/onyx-bio |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated